NLRP3 and diabetic kidney disease: Abd El-Khalik et al. conducted a study proposing the potential of ZnO-NPs to mitigate diabetic nephropathy progression by influencing the interplay between autophagy and the Nrf2/TXNIP/NLRP3 inflammasome signaling pathways [26].